Additional Information
Book Details
Abstract
Basic Pharmacology for Nurses is a modern classic. Known for its impeccably accurate drug content and practical applications of the nursing process, this trusted text consistently emphasizes health promotion through monitoring and patient education. Introductory units ground your knowledge in the basic principles of pharmacology and medication administration, while subsequent body-system units prepare you to apply the nursing process to every major disorder.
- UNIQUE! Two-tiered application of the nursing process provides the general principles of care, along with specific nursing implications for each drug class or individual drug.
- Meticulously accurate and updated drug content keeps the book in step with the latest FDA approvals, withdrawals, and changes in therapeutic uses.
- UNIQUE! Introduction to Cardiovascular Disease and Metabolic Syndrome sets the stage for an understanding of the progression of cardiovascular disease and the pharmacologic treatment of that progression.
- UNIQUE! Patient Teaching boxes equip you for health teaching related to medications.
- LPN Threads design presents information in an easy to understand and visually engaging manner.
- NEW! Increased emphasis on medication safety prepares you for a clinical environment that is more focused than ever on reducing drug errors.
-
NEW! Updated and added coverage
keeps you up to date with the latest information on genetics, pharmacogenomics, and racial/gender factors in drug actions.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front cover | cover | ||
| Inside front cover | ifc1 | ||
| Basic Pharmacology for Nurses, 16/e | i | ||
| Copyright page | ii | ||
| Evolve page | iii | ||
| Dedication | iv | ||
| Ancillary Writers | v | ||
| Reviewers | vi | ||
| LPN Advisory Board | viii | ||
| Preface | ix | ||
| Organization and Special Features | ix | ||
| Content Threads | ix | ||
| Table of Contents | ix | ||
| Chapter Organization | ix | ||
| Special Features | x | ||
| New to This Edition | x | ||
| Teaching and Learning Package | x | ||
| For Students | x | ||
| For Instructors | x | ||
| Special Features | xi | ||
| Study Guide | xi | ||
| Table of Contents | xiii | ||
| Unit I Foundations of Pharmacology | 1 | ||
| 1 Drug Definitions, Standards, and Information Sources | 1 | ||
| Objectives | 1 | ||
| Key Terms | 1 | ||
| Drug Names, CLASSIFICATIONS, Standards, Legislation, and Development in the United States | 1 | ||
| Drug Names | 1 | ||
| Drug Classifications | 2 | ||
| Sources of Drug Information | 2 | ||
| Objectives | 2 | ||
| Package Inserts | 2 | ||
| Nursing Journals | 4 | ||
| Electronic Databases | 4 | ||
| Drug Legislation | 4 | ||
| Objectives | 4 | ||
| Key Term | 4 | ||
| Federal Food, Drug, and Cosmetic Act | 4 | ||
| Controlled Substances Act | 4 | ||
| Schedule I Drugs | 4 | ||
| Schedule II Drugs | 4 | ||
| Schedule III Drugs | 5 | ||
| Schedule IV Drugs | 5 | ||
| Schedule V Drugs | 5 | ||
| Drug Enforcement Administration | 5 | ||
| Controlled Substances in Hospitals | 5 | ||
| Possession of Controlled Substances by Individuals | 5 | ||
| Effectiveness of Drug Legislation | 5 | ||
| New Drug Development | 6 | ||
| Objective | 6 | ||
| Key Terms | 6 | ||
| Preclinical Research and Development Stage | 6 | ||
| Clinical Research and Development Stage | 7 | ||
| Fast Tracking | 7 | ||
| Parallel Tracking | 7 | ||
| New Drug Application Review | 7 | ||
| Postmarketing Surveillance Stage | 7 | ||
| Black Box Warning | 7 | ||
| Rare Diseases and the Development of Orphan Drugs | 8 | ||
| Drug Names, Standards, and Legislation in Canada | 8 | ||
| Objectives | 8 | ||
| Key Terms | 8 | ||
| Canadian Drug Names | 8 | ||
| Official Drug | 8 | ||
| Chemical Name | 8 | ||
| Proper Name or Generic Name | 8 | ||
| Brand Name | 9 | ||
| Sources of Canadian Drug Standards | 9 | ||
| Canadian Drug Legislation | 9 | ||
| Food and Drugs Act and Regulations | 9 | ||
| Controlled Drugs and Substances Act | 9 | ||
| Nonprescription Drugs | 10 | ||
| Get Ready for the NCLEX® Examination! | 10 | ||
| Additional Learning Resources | 10 | ||
| Review Questions for the NCLEX® Examination | 10 | ||
| 2 Basic Principles of Drug Action and Drug Interactions | 12 | ||
| Objectives | 12 | ||
| Key Terms | 12 | ||
| Basic Principles Related to Drug Therapy | 12 | ||
| Drug Responses in the Body | 12 | ||
| Drug Interactions in the Body | 12 | ||
| Routes of Drug Administration | 12 | ||
| Liberation, Absorption, Distribution, Metabolism, and Excretion | 12 | ||
| Liberation | 13 | ||
| Absorption | 13 | ||
| Distribution | 13 | ||
| Metabolism | 14 | ||
| Excretion | 14 | ||
| Half-Life | 14 | ||
| Drug Actions | 15 | ||
| Objectives | 15 | ||
| Key Terms | 15 | ||
| Drug Blood Level | 16 | ||
| Adverse Effects of Drugs | 16 | ||
| Idiosyncratic Reaction | 17 | ||
| Allergic Reaction | 17 | ||
| Drug Interactions | 17 | ||
| Objectives | 17 | ||
| Key Terms | 17 | ||
| Alteration of Absorption | 17 | ||
| Alteration of Distribution | 17 | ||
| Alteration of Metabolism | 18 | ||
| Alteration of Excretion | 19 | ||
| Drugs That Enhance the Pharmacologic Effects of Other Drugs | 19 | ||
| Get Ready for the NCLEX® Examination! | 19 | ||
| Additional Learning Resources | 19 | ||
| Review Questions for the NCLEX® Examination | 19 | ||
| 3 Drug Action Across the Life Span | 20 | ||
| Objectives | 20 | ||
| Key Terms | 20 | ||
| Factors That Affect Drug Therapy | 20 | ||
| Age | 20 | ||
| Body Weight | 20 | ||
| Gender | 21 | ||
| Metabolic Rate | 21 | ||
| Illness | 21 | ||
| Psychology | 21 | ||
| Tolerance | 21 | ||
| Dependence | 22 | ||
| Cumulative Effect | 22 | ||
| Factors That Influence Drug Actions | 22 | ||
| Absorption | 22 | ||
| Age | 22 | ||
| Gender | 23 | ||
| Distribution | 23 | ||
| Age and Gender | 23 | ||
| Metabolism | 24 | ||
| Age | 24 | ||
| Gender | 24 | ||
| Excretion | 24 | ||
| Age | 25 | ||
| Therapeutic Drug Monitoring | 25 | ||
| Nursing Implications Whe Monitoring Drug Therapy | 26 | ||
| Monitoring Parameters | 26 | ||
| Pediatric Patients | 27 | ||
| Geriatric Patients | 28 | ||
| Pregnant Patients | 30 | ||
| Breastfeeding Infants | 31 | ||
| Genetics and Drug Metabolism | 32 | ||
| Get Ready for the NCLEX® Examination! | 33 | ||
| Additional Learning Resources | 33 | ||
| Review Questions for the NCLEX® Examination | 33 | ||
| 4 The Nursing Process and Pharmacology | 34 | ||
| Objectives | 34 | ||
| Key Terms | 34 | ||
| The Nursing Process | 34 | ||
| Assessment | 36 | ||
| Objectives | 36 | ||
| Key Term | 36 | ||
| Nursing Diagnosis | 37 | ||
| Objectives | 37 | ||
| Key Terms | 37 | ||
| Collaborative Problems | 39 | ||
| Focused Assessment | 39 | ||
| Planning | 39 | ||
| Objectives | 39 | ||
| Key Terms | 39 | ||
| Priority Setting | 40 | ||
| Measurable Goal and Outcome Statements | 40 | ||
| Nursing Outcomes Classification | 41 | ||
| Implementation | 41 | ||
| Objective | 41 | ||
| Key Terms | 41 | ||
| Nursing Actions | 42 | ||
| Nursing Action or Intervention Statements | 42 | ||
| Nursing Interventions Classification | 42 | ||
| Anticipated Therapeutic and Expected Outcome Statements | 42 | ||
| Evaluation | 42 | ||
| Relating the Nursing Process to Pharmacology | 43 | ||
| Objectives | 43 | ||
| Key Terms | 43 | ||
| Assessment | 43 | ||
| Nursing Diagnoses | 44 | ||
| Planning | 44 | ||
| Implementation | 45 | ||
| Dependent Nursing Actions | 45 | ||
| Interdependent Nursing Actions | 45 | ||
| Independent Nursing Actions | 45 | ||
| Evaluation | 46 | ||
| Get Ready for the NCLEX® Examination! | 47 | ||
| Additional Learning Resources | 47 | ||
| Review Questions for the NCLEX® Examination | 47 | ||
| 5 Patient Education to Promote Health | 48 | ||
| Objective | 48 | ||
| Unit II Illustrated Atlas of Medication Administration and Math Review | 58 | ||
| 6 A Review of Arithmetic | 58 | ||
| Fractions | 58 | ||
| Objective | 58 | ||
| Key Terms | 58 | ||
| Common Fractions | 58 | ||
| Types of Common Fractions | 59 | ||
| Working with Fractions | 59 | ||
| Addition | 59 | ||
| Adding Common Fractions | 59 | ||
| Adding Mixed Numbers | 60 | ||
| Subtraction | 60 | ||
| Subtracting Fractions | 60 | ||
| Subtracting Mixed Numbers | 61 | ||
| Multiplication | 61 | ||
| Multiplying a Whole Number by a Fraction | 61 | ||
| Multiplying Two Fractions | 61 | ||
| Multiplying Mixed Numbers | 61 | ||
| Division | 62 | ||
| Dividing Fractions | 62 | ||
| Dividing With a Mixed Number | 62 | ||
| Fractions as Decimals | 62 | ||
| Using Cancellation to Speed Your Work | 62 | ||
| Decimal Fractions | 62 | ||
| Objectives | 62 | ||
| Multiplying Decimals | 63 | ||
| Multiplying Whole Numbers and Decimals | 63 | ||
| Rounding the Answer | 63 | ||
| Multiplying a Decimal by a Decimal | 63 | ||
| Multiplying Numbers With Zero | 63 | ||
| Dividing Decimals | 64 | ||
| Changing Decimals to Common Fractions | 64 | ||
| Changing Common Fractions to Decimal Fractions | 64 | ||
| Percents | 64 | ||
| Objective | 64 | ||
| Determining the Percent That One Number Is of Another | 64 | ||
| Changing Percents to Fractions | 64 | ||
| Changing Percents to Decimal Fractions | 65 | ||
| Changing Common Fractions to Percents | 65 | ||
| Changing Decimal Fractions to Percents | 65 | ||
| Points to Remember When Reading Decimals | 65 | ||
| Ratios | 65 | ||
| Objective | 65 | ||
| Changing Ratio to Percent | 66 | ||
| Changing Percent to Ratio | 66 | ||
| Simplifying Ratios | 66 | ||
| Proportions | 66 | ||
| Systems of Weights and Measures | 66 | ||
| Objectives | 66 | ||
| Key Terms | 67 | ||
| Household Measurements | 67 | ||
| Common Household Equivalents | 67 | ||
| Metric System | 67 | ||
| Units of Length (Meter) | 67 | ||
| Units of Volume (Liter) | 67 | ||
| Units of Weight (Gram) | 67 | ||
| Other Prefixes | 67 | ||
| Common Metric Equivalents | 68 | ||
| Conversion of Metric Units | 68 | ||
| Converting Milligrams (Metric) to Grams (Metric) (1000 mg = 1 g) | 68 | ||
| Solid Dosage for Oral Administration | 68 | ||
| Conversion Problems | 69 | ||
| Converting Pounds to Kilograms (1 kg = 2.2 lb) | 70 | ||
| Calculating Dosage Ranges for mg/kg/day | 70 | ||
| Calculations With Other Forms of Measure That Do Not Require Conversions | 70 | ||
| Sliding Supplemental Scale Insulin Dosage | 71 | ||
| Calculation of Intravenous Fluid and Medication Administration Rates | 71 | ||
| Objective | 71 | ||
| Key Terms | 71 | ||
| Intravenous Fluid Orders, Drip Rates, Pumps, and Rounding | 72 | ||
| Rounding | 72 | ||
| Volumetric and Nonvolumetric Pumps | 72 | ||
| Calculation of Flow Rates | 72 | ||
| Milliliters per Hour (mL/hr) | 72 | ||
| Calculating Rates of Infusion for Times Other Than 1 Hour | 73 | ||
| Drops per Minute (gtt/min) | 73 | ||
| Drugs Ordered in Units per Hour or Milligrams per Hour | 73 | ||
| Fahrenheit and Centigrade (Celsius) Temperatures | 74 | ||
| Objective | 74 | ||
| Key Terms | 74 | ||
| Formula for Converting Fahrenheit Temperature to Centigrade Temperature | 75 | ||
| Formula for Converting Centigrade Temperature to Fahrenheit Temperature | 75 | ||
| Get Ready for the NCLEX® Examination! | 76 | ||
| Additional Learning Resources | 76 | ||
| Answers to Practice Questions | 76 | ||
| Working With Fractions | 76 | ||
| Adding Common Fractions | 76 | ||
| Adding Mixed Numbers | 76 | ||
| Subtracting Fractions | 76 | ||
| Subtracting Mixed Numbers | 76 | ||
| Multiplying a Whole Number by a Fraction | 76 | ||
| Multiplying Mixed Numbers | 76 | ||
| Fractions as Decimals | 76 | ||
| Rounding the Answer | 76 | ||
| Changing Decimals to Common Fractions | 76 | ||
| Changing Common Fractions to Decimal Fractions | 76 | ||
| Changing Percents to Fractions | 76 | ||
| Changing Percents to Decimal Fractions | 76 | ||
| Changing Common Fractions to Percents | 76 | ||
| Changing Decimal Fractions to Percents | 76 | ||
| Changing Ratio to Percent | 77 | ||
| Changing Percent to Ratio | 77 | ||
| Simplifying Ratios | 77 | ||
| Proportions | 77 | ||
| Common Metric Equivalents | 77 | ||
| Converting Milligrams (Metric) to Grams (Metric) | 77 | ||
| Converting Weight to Kilograms | 77 | ||
| Milliliters per Hour (mL/hr) | 77 | ||
| Calculating Rates of Infusion for Times Other Than 1 Hour | 77 | ||
| Drops per Minute | 77 | ||
| Drugs Ordered in Units per Hour or Milligrams per Hour | 77 | ||
| Formula for Converting Fahrenheit Temperature to Centigrade Temperature | 78 | ||
| Formula for Converting Centigrade Temperature to Fahrenheit Temperature | 78 | ||
| 7 Principles of Medication Administration and Medication Safety | 79 | ||
| Objectives | 79 | ||
| Key Terms | 79 | ||
| Legal and Ethical Considerations | 79 | ||
| Standards of Care | 79 | ||
| Patient Charts | 80 | ||
| Contents of Patient Charts | 80 | ||
| Summary Sheet | 80 | ||
| Consent Forms | 80 | ||
| Physician’s Order Form | 80 | ||
| History and Physical Examination Form | 80 | ||
| Progress Notes | 81 | ||
| Critical Pathways | 81 | ||
| Evidence-Based Medicine | 81 | ||
| Nurses’ Notes | 83 | ||
| Nursing Care Plans | 84 | ||
| Laboratory Tests Record | 86 | ||
| Graphic Record | 86 | ||
| Flow Sheets | 86 | ||
| Consultation Reports | 86 | ||
| Other Diagnostic Reports | 86 | ||
| Medication Profile and Medication Administration Record | 87 | ||
| PRN or Unscheduled Medication Record | 89 | ||
| Patient Education Record | 90 | ||
| Kardex Records | 90 | ||
| Evolving Charting Methodologies | 91 | ||
| Drug Distribution Systems | 91 | ||
| Objective | 91 | ||
| Key Terms | 91 | ||
| Floor or Ward Stock System | 91 | ||
| Individual Prescription Order System | 91 | ||
| Computer-Controlled Dispensing System | 92 | ||
| Unit-Dose System | 93 | ||
| Long-Term Care Unit-Dose System | 93 | ||
| Narcotic Control Systems | 94 | ||
| Disposal of Unused Medicines | 96 | ||
| Medication Orders | 96 | ||
| Objective | 96 | ||
| Key Terms | 96 | ||
| Types of Medication Orders | 97 | ||
| Verbal Orders | 97 | ||
| Electronic Transmission of Patient Orders | 97 | ||
| Medication Safety | 97 | ||
| Objective | 97 | ||
| Key Terms | 97 | ||
| Technology and Prevention of Adverse Drug Events | 98 | ||
| High-Alert Medications | 98 | ||
| Medication Reconciliation | 98 | ||
| Sound-Alike Medications | 99 | ||
| Nurse’s Responsibilities | 99 | ||
| Verification | 99 | ||
| Transcription | 99 | ||
| Reporting Variance | 100 | ||
| Seven Rights Of Drug Administration | 100 | ||
| Objectives | 100 | ||
| Right Drug | 100 | ||
| Right Indication | 100 | ||
| Right Time | 100 | ||
| Standard Abbreviations | 100 | ||
| Standardized Administration Times | 100 | ||
| Maintenance of Consistent Blood Levels | 100 | ||
| Maximum Drug Absorption | 100 | ||
| Diagnostic Testing | 101 | ||
| PRN Medications | 101 | ||
| Right Dose | 101 | ||
| Abnormal Hepatic or Renal Function | 101 | ||
| Pediatric and Older Patients | 101 | ||
| Nausea and Vomiting | 101 | ||
| Accurate Dose Forms | 101 | ||
| Accurate Calculations | 101 | ||
| Correct Measuring Devices | 101 | ||
| Right Patient | 102 | ||
| Pediatric Patients | 102 | ||
| Older Patients | 102 | ||
| Right Route | 102 | ||
| Right Documentation | 102 | ||
| Before Discharge | 103 | ||
| Get Ready for the NCLEX® Examination! | 104 | ||
| Additional Learning Resources | 104 | ||
| Review Questions for the NCLEX® Examination | 104 | ||
| 8 Percutaneous Administration | 105 | ||
| Objectives | 105 | ||
| Key Terms | 105 | ||
| Administration of Topical Medications to the Skin | 105 | ||
| Dose Forms | 105 | ||
| Creams | 105 | ||
| Lotions | 105 | ||
| Ointments | 105 | ||
| Dressings | 105 | ||
| Procedure Protocol | 106 | ||
| Administration of Creams, Lotions, and Ointments | 106 | ||
| Equipment | 106 | ||
| Sites | 106 | ||
| Techniques | 106 | ||
| Patient Teaching | 106 | ||
| Documentation | 107 | ||
| Patch Testing For Allergens | 107 | ||
| Objectives | 107 | ||
| Key Terms | 107 | ||
| Equipment | 107 | ||
| Sites | 107 | ||
| Technique | 107 | ||
| Patient Teaching | 108 | ||
| Documentation | 109 | ||
| Administration of Nitroglycerin Ointment | 109 | ||
| Objectives | 109 | ||
| Dose Form | 109 | ||
| Equipment | 109 | ||
| Sites | 109 | ||
| Techniques | 109 | ||
| Patient Teaching | 110 | ||
| Documentation | 110 | ||
| Administration of Transdermal Drug Delivery Systems | 110 | ||
| Objective | 110 | ||
| Key Term | 110 | ||
| Dose Form | 110 | ||
| Equipment | 111 | ||
| Sites | 111 | ||
| Techniques | 111 | ||
| Patient Teaching | 111 | ||
| Unit III Drugs That Affect the Autonomic and Central Nervous Systems | 201 | ||
| 13 Drugs That Affect the Central Nervous System | 201 | ||
| Objectives | 201 | ||
| Key Terms | 201 | ||
| The Central and Autonomic Nervous Systems | 201 | ||
| The Autonomic Nervous System | 202 | ||
| Drug Class: Adrenergic Agents | 202 | ||
| Actions | 202 | ||
| Uses | 203 | ||
| Nursing Implications for Adrenergic Agents | 203 | ||
| Premedication Assessment | 203 | ||
| Availability, Dosage, and Administration | 203 | ||
| Monitoring | 203 | ||
| Common Adverse Effects | 204 | ||
| Unit IV Drugs That Affect the Cardiovascular System | 338 | ||
| 21 Introduction to Cardiovascular Disease and Metabolic Syndrome | 338 | ||
| Objectives | 338 | ||
| Key Terms | 338 | ||
| Cardiovascular Diseases | 338 | ||
| Metabolic Syndrome | 338 | ||
| Resulting Conditions | 339 | ||
| Risk Factors | 339 | ||
| Obesity and Sedentary Lifestyle | 339 | ||
| Alcohol and Smoking | 340 | ||
| Genetic Factors | 340 | ||
| Treatment | 340 | ||
| Drug Therapy to Treat Underlying Conditions for Metabolic Syndrome | 342 | ||
| Hypertension | 342 | ||
| Dyslipidemia | 342 | ||
| Type 2 Diabetes Mellitus | 342 | ||
| Get Ready for the NCLEX® Examination! | 343 | ||
| Key Points | 343 | ||
| Additional Learning Resources | 343 | ||
| Online Resources | 343 | ||
| Review Questions for the NCLEX® Examination | 343 | ||
| 22 Drugs Used to Treat Dyslipidemias | 344 | ||
| Objectives | 344 | ||
| Key Terms | 344 | ||
| Atherosclerosis | 344 | ||
| Types Of lipoproteins | 344 | ||
| Treatment of Hyperlipidemias | 345 | ||
| Drug Therapy for Hyperlipidemias | 346 | ||
| Actions | 346 | ||
| Uses | 346 | ||
| Nursing Implications for Hyperlipidemia Therapy | 346 | ||
| Assessment | 346 | ||
| History of Risk Factors. | 346 | ||
| Hypertension. | 346 | ||
| Smoking. | 346 | ||
| Dietary Habits | 346 | ||
| Glucose Intolerance. | 346 | ||
| Elevated Serum Lipid Levels. | 346 | ||
| Obesity. | 347 | ||
| Psychomotor Functions | 347 | ||
| Patient Education | 347 | ||
| Nutrition. | 347 | ||
| Vitamin K Deficiency. | 347 | ||
| Follow-Up Care. | 347 | ||
| Relating to Medication Regimen. | 347 | ||
| Fostering Health Maintenance | 347 | ||
| Written Record. | 347 | ||
| Drug Class: Bile-Acid–binding Resins | 348 | ||
| Actions | 348 | ||
| Uses | 348 | ||
| Therapeutic Outcomes | 348 | ||
| Nursing Implications for Bile-Acid–Binding Resins | 348 | ||
| Premedication Assessment | 348 | ||
| Availability | 348 | ||
| Dosage and Administration | 348 | ||
| Monitoring | 348 | ||
| Common Adverse Effects | 348 | ||
| Gastrointestinal | 348 | ||
| Constipation, Bloating, Fullness, Nausea, Flatulence. | 348 | ||
| Drug Interactions | 348 | ||
| Digoxin, Warfarin, Thyroid Hormones, Thiazide Diuretics, Phenobarbital, Nonsteroidal Anti-Inflammatory Agents, Tetracycline, Beta-Blocking Agents, Gemfibrozil, Glipizide, Glyburide, Oral Contraceptives, Phenytoin. | 348 | ||
| Amiodarone. | 348 | ||
| Fat-Soluble Vitamins (D, E, A, and K), Folic Acid. | 348 | ||
| Drug Class: Niacin | 349 | ||
| Actions | 349 | ||
| Uses | 349 | ||
| Therapeutic Outcomes | 349 | ||
| Nursing Implications for Niacin | 349 | ||
| Premedication Assessment | 349 | ||
| Availability | 349 | ||
| Dosage and Administration | 349 | ||
| Monitoring | 349 | ||
| Common Adverse Effects | 349 | ||
| Integumentary. | 349 | ||
| Neurologic. | 349 | ||
| Gastrointestinal | 349 | ||
| Nausea, Gas, and Abdominal Discomfort and Pain. | 349 | ||
| Cardiovascular | 349 | ||
| Dizziness, Faintness, Hypotension. | 349 | ||
| Unit V Drugs That Affect the Respiratory System | 471 | ||
| 30 Drugs Used to Treat Upper Respiratory Disease | 471 | ||
| Objectives | 471 | ||
| Key Terms | 471 | ||
| Upper Respiratory Tract Anatomy and Physiology | 471 | ||
| Common Upper Respiratory Diseases | 472 | ||
| Treatment of Upper Respiratory Diseases | 473 | ||
| Common Cold | 473 | ||
| Allergic Rhinitis | 474 | ||
| Rhinitis Medicamentosa | 474 | ||
| Drug Therapy for Upper Respiratory Diseases | 474 | ||
| Actions and Uses | 474 | ||
| Nursing Implications for Upper Respiratory Diseases | 475 | ||
| ■ Assessment | 475 | ||
| Description of Symptoms | 475 | ||
| History of Treatment | 475 | ||
| History of Concurrent Medical Problems. | 475 | ||
| Patient Education and Health Promotion | 475 | ||
| Fostering Health Maintenance | 475 | ||
| Drug Class: Sympathomimetic Decongestants | 475 | ||
| Actions | 475 | ||
| Uses | 476 | ||
| Therapeutic Outcome | 476 | ||
| Nursing Implications for Sympathomimetic Decongestants | 476 | ||
| ■ Premedication Assessment | 476 | ||
| ■ Availability | 476 | ||
| ■ Dosage and Administration | 476 | ||
| ■ Monitoring | 477 | ||
| Common Adverse Effects | 477 | ||
| Respiratory | 477 | ||
| Mild Nasal Irritation. | 477 | ||
| Serious Adverse Effects | 477 | ||
| Cardiovascular | 477 | ||
| Hypertension. | 477 | ||
| ■ Drug Interactions | 477 | ||
| Drugs That Enhance Toxic Effects. | 477 | ||
| Methyldopa and Reserpine. | 477 | ||
| Drug Class: Antihistamines | 477 | ||
| Actions | 477 | ||
| Uses | 477 | ||
| Therapeutic Outcome | 477 | ||
| Nursing Implications for Antihistamines | 477 | ||
| ■ Premedication Assessment | 477 | ||
| Unit VI Drugs That Affect the Digestive System | 511 | ||
| 32 Drugs Used to Treat Oral Disorders | 511 | ||
| Objectives | 511 | ||
| Key Terms | 511 | ||
| Mouth Disorders | 511 | ||
| Drug Therapy for Mouth Disorders | 513 | ||
| Cold Sores | 513 | ||
| Canker Sores | 513 | ||
| Mucositis | 513 | ||
| Plaque | 514 | ||
| Halitosis | 514 | ||
| Xerostomia | 514 | ||
| Nursing Implications for Oral Health Therapy | 514 | ||
| ■ Assessment | 514 | ||
| Drug History. | 514 | ||
| Dental History | 514 | ||
| Oral Cavity | 514 | ||
| ■ Implementation | 514 | ||
| Cold Sores | 515 | ||
| Canker Sores | 515 | ||
| Mucositis. | 515 | ||
| Plaque. | 515 | ||
| Halitosis. | 515 | ||
| Xerostomia. | 515 | ||
| Dentures. | 515 | ||
| Patient Education and Health Promotion | 515 | ||
| Fostering Health Maintenance | 516 | ||
| Drug Class: Dentifrices | 516 | ||
| Unit VII Drugs That Affect the Endocrine System | 560 | ||
| 36 Drugs Used to Treat Diabetes Mellitus | 560 | ||
| Objectives | 560 | ||
| Key Terms | 560 | ||
| Diabetes Mellitus | 560 | ||
| Complications of Diabetes Mellitus | 562 | ||
| Treatment of Diabetes Mellitus | 563 | ||
| Drug Therapy for Diabetes Mellitus | 564 | ||
| Nursing Implications for Patients With Diabetes Mellitus | 565 | ||
| Assessment | 566 | ||
| Description of Current Symptoms | 566 | ||
| Patient’s Understanding of Diabetes Mellitus | 566 | ||
| Psychosocial Assessment | 566 | ||
| Nutrition | 566 | ||
| Activity and Exercise | 567 | ||
| Medications. | 567 | ||
| Monitoring. | 567 | ||
| Physical Assessment. | 567 | ||
| Implementation | 567 | ||
| Patient Education and Health Promotion | 568 | ||
| Knowledge. | 568 | ||
| Psychological Adjustment | 568 | ||
| Smoking. | 568 | ||
| Nutrition | 568 | ||
| Activity and Exercise | 569 | ||
| Medication | 570 | ||
| Hypoglycemia. | 571 | ||
| Unit VIII Drugs That Affect the Reproductive System | 621 | ||
| 40 Drugs Used in Obstetrics | 621 | ||
| Objectives | 621 | ||
| Key Terms | 621 | ||
| Obstetrics | 621 | ||
| Nursing Implications for Obstetrics | 621 | ||
| Assessment | 621 | ||
| Prenatal Assessment. | 621 | ||
| Nutritional History | 621 | ||
| Elimination Pattern | 621 | ||
| Psychosocial Culture History | 622 | ||
| Medication History. | 622 | ||
| Physical Examination. | 622 | ||
| Assessment During First, Second, and Third Trimesters. | 622 | ||
| Assessment of the Pregnant Patient at Risk. | 622 | ||
| Assessment During Normal Labor and Delivery | 623 | ||
| History of Pregnancy. | 623 | ||
| Physical Examination. | 623 | ||
| Assessment After Delivery and During Postpartum Care | 623 | ||
| Assessment of the Neonate | 625 | ||
| Implementation | 625 | ||
| Prenatal | 625 | ||
| Complications of Pregnancy | 625 | ||
| Preterm Labor | 625 | ||
| Premature Rupture of Membranes | 626 | ||
| Gestational Diabetes Mellitus (GDM) | 626 | ||
| Pregnancy Hypertension Disorders (Preeclampsia, Eclampsia) | 626 | ||
| Termination of Pregnancy | 626 | ||
| Normal Labor and Delivery | 627 | ||
| Immediate Neonatal Care. | 627 | ||
| Airway. | 627 | ||
| Clamping the Umbilical Cord. | 627 | ||
| Health Status. | 627 | ||
| Temperature Maintenance. | 627 | ||
| Eye Prophylaxis. | 628 | ||
| Other Procedures. | 628 | ||
| Postpartum Care. | 628 | ||
| Patient Education and Health Promotion | 629 | ||
| Adequate Rest and Relaxation. | 629 | ||
| Activity and Exercise. | 629 | ||
| Employment. | 629 | ||
| General Personal Hygiene. | 629 | ||
| Clothing. | 629 | ||
| Oral Hygiene. | 629 | ||
| Sexual Activity. | 629 | ||
| Smoking and Alcohol. | 629 | ||
| Nutritional Needs. | 629 | ||
| Bowel Habits. | 630 | ||
| Douching. | 630 | ||
| Discomforts of Pregnancy. | 630 | ||
| Complications of Pregnancy. | 630 | ||
| At Discharge | 630 | ||
| Fostering Health Maintenance | 630 | ||
| Written Record. | 630 | ||
| Drug Therapy in Pregnancy | 630 | ||
| Drug Class: Uterine Stimulants | 630 | ||
| Uses | 630 | ||
| Induction of Labor | 630 | ||
| Augmentation of Labor | 630 | ||
| Postpartum Atony and Hemorrhage | 630 | ||
| Therapeutic (Induced) Abortion | 631 | ||
| Actions | 631 | ||
| Uses | 631 | ||
| Therapeutic Outcomes | 631 | ||
| Nursing Implications for Dinoprostone | 631 | ||
| Premedication Assessment | 631 | ||
| Availability | 631 | ||
| Dosage and Administration | 631 | ||
| Monitoring | 631 | ||
| Common Adverse Effects | 631 | ||
| Gastrointestinal | 631 | ||
| Nausea, Vomiting, Diarrhea. | 631 | ||
| Thermoregulation | 632 | ||
| Fever. | 632 | ||
| Serious Adverse Effects | 632 | ||
| Cardiovascular | 632 | ||
| Orthostatic Hypotension. | 632 | ||
| Unit IX Drugs That Affect Other Body Systems | 666 | ||
| 42 Drugs Used to Treat Disorders of the Urinary System | 666 | ||
| Objectives | 666 | ||
| Key Terms | 666 | ||
| Urinary Tract Infections | 666 | ||
| Nursing Implications for Urinary System Disease | 666 | ||
| Assessment | 666 | ||
| History of Urinary Tract Symptoms | 666 | ||
| History of Current Symptoms | 667 | ||
| Medication History. | 667 | ||
| Nutritional History | 667 | ||
| Laboratory and Diagnostic Studies. | 667 | ||
| Implementation | 667 | ||
| Patient Education and Health Promotion | 669 | ||
| For Incontinence | 669 | ||
| For Urinary Tract Infections | 669 | ||
| For Urinary Retention. | 669 | ||
| Medications | 669 | ||
| Fostering Health Maintenance | 669 | ||
| Written Record. | 669 | ||
| Drug Therapy for Urinary Tract Infections | 669 | ||
| Urinary Antimicrobial Agents | 669 | ||
| Actions | 669 | ||
| Uses | 669 | ||
| Drug Class: Fosfomycin Antibiotics | 670 | ||
| Unit X Drugs That Affect the General Health of the Body | 790 | ||
| 47 Nutrition | 790 | ||
| Objectives | 790 | ||
| Key Terms | 790 | ||
| Principles of Nutrition | 790 | ||
| Methods for Assessing Nutrition | 791 | ||
| Governmental Guidelines | 791 | ||
| Alternatives to Governmental Guidelines | 793 | ||
| Counting Calories | 795 | ||
| Dietary Reference Intakes | 795 | ||
| Macronutrients | 795 | ||
| Vitamins | 797 | ||
| Minerals | 797 | ||
| Water | 799 | ||
| Physical Activity | 799 | ||
| Malnutrition | 800 | ||
| Therapy for Malnutrition | 800 | ||
| Nursing Implications for Nutritional Support | 801 | ||
| n Assessment | 801 | ||
| History of Nutritional Deficit. | 801 | ||
| Nutritional History | 801 | ||
| Physical Changes Related to a Malnourished State | 801 | ||
| Implementation | 802 | ||
| Monitoring Tube Feedings | 802 | ||
| Monitoring Peripheral Parenteral Nutrition (PPN) | 802 | ||
| Monitoring Central Parenteral Nutrition (CPN) | 802 | ||
| Patient Education and Health Promotion | 803 | ||
| Fostering Health Maintenance | 803 | ||
| Written Record. | 803 | ||
| Enteral Nutrition | 804 | ||
| Actions | 804 | ||
| Uses | 804 | ||
| Therapeutic Outcomes | 804 | ||
| Nursing Implications for Enteral Nutrition | 804 | ||
| Premedication Assessment | 804 | ||
| Availability | 804 | ||
| Dosage and Administration | 804 | ||
| Administration of Medicines to the Tube-Fed Patient | 804 | ||
| n Monitoring | 805 | ||
| Common Adverse Effects | 805 | ||
| Hematologic | 805 | ||
| Hyperglycemia. | 805 | ||
| Serious Adverse Effects | 805 | ||
| Respiratory | 805 | ||
| Pulmonary Complications. | 805 | ||
| Gastrointestinal | 805 | ||
| Diarrhea or Constipation. | 805 | ||
| Nausea, Vomiting, Increased Residual Volumes. | 806 | ||
| Hypersensitivity, Immune System | 806 | ||
| Rash, Chills, Fever, Respiratory Difficulty. | 806 | ||
| n Drug Interactions | 806 | ||
| Alcohol and Disulfiram, Metronidazole, and Tinidazole. | 806 | ||
| Tetracycline, Doxycycline, Ciprofloxacin, Levofloxacin. | 806 | ||
| Itraconazole (Capsules), Ganciclovir, Ritonavir. | 806 | ||
| Itraconazole (Suspension), Didanosine, Indinavir. | 806 | ||
| Alendronate, Risedronate, Ibandronate, Tiludronate. | 806 | ||
| Monoamine Oxidase Inhibitors (MAOIs: Tranylcypromine, Phenelzine, Isocarboxazid). | 806 | ||
| Warfarin. | 806 | ||
| Grapefruit Juice. | 806 | ||
| Potentially Serious Interactions With Grapefruit Juice and Other Medicines | 806 | ||
| Calcium Channel Blockers. | 806 | ||
| Carbamazepine. | 806 | ||
| Antidepressant and Antianxiety Medicines. | 806 | ||
| Cyclosporine. | 806 | ||
| Caffeine. | 806 | ||
| Parenteral Nutrition | 807 | ||
| Actions | 807 | ||
| Uses | 807 | ||
| Therapeutic Outcomes | 807 | ||
| Nursing Implications for Parenteral Nutrition | 807 | ||
| Premedication Assessment | 807 | ||
| Availability | 807 | ||
| Dosage and Administration | 807 | ||
| Monitoring | 807 | ||
| Common Adverse Effects | 807 | ||
| Hematologic | 807 | ||
| Hyperglycemia. | 807 | ||
| Serious Adverse Effects | 808 | ||
| Hematologic | 808 | ||
| Hypoglycemia. | 808 | ||
| Fluid Imbalance. | 808 | ||
| Electrolyte Imbalances. | 808 | ||
| Vitamin Deficiencies. | 808 | ||
| Gastrointestinal | 808 | ||
| Hepatotoxicity. | 808 | ||
| Hypersensitivity, Immune System | 808 | ||
| Rash, Chills, Fever, Respiratory Difficulty. | 808 | ||
| n Drug Interactions | 808 | ||
| Get Ready for the NCLEX® Examination! | 809 | ||
| Key Points | 809 | ||
| Additional Learning Resources | 809 | ||
| Review Questions for the NCLEX® Examination | 809 | ||
| 48 Herbal and Dietary Supplement Therapy | 811 | ||
| Objectives | 811 | ||
| Key Terms | 811 | ||
| Herbal Medicines, Dietary Supplements, and Rational Therapy | 811 | ||
| Regulatory Legislation | 811 | ||
| Independent Product Testing | 811 | ||
| Nursing Implications for Herbal and Diet Supplement Therapy | 812 | ||
| Assessment | 812 | ||
| History of Symptoms. | 812 | ||
| Medication History | 812 | ||
| Cultural and Ethnic Beliefs. | 812 | ||
| Implementation | 812 | ||
| Patient Education and Health Promotion | 813 | ||
| Expectations of Therapy. | 813 | ||
| Fostering Health Maintenance | 813 | ||
| Written Record. | 813 | ||
| Herbal Therapy | 813 | ||
| Actions | 813 | ||
| Bibliography | 858 | ||
| Online Resources | 858 | ||
| Publications | 859 | ||
| Illustration Credits | 862 | ||
| Chapter 1 | 862 | ||
| Chapter 4 | 862 | ||
| Chapter 5 | 862 | ||
| Chapter 7 | 862 | ||
| Chapter 8 | 862 | ||
| Chapter 9 | 862 | ||
| Chapter 10 | 862 | ||
| Chapter 12 | 862 | ||
| Chapter 15 | 862 | ||
| Chapter 20 | 862 | ||
| Chapter 21 | 862 | ||
| Chapter 23 | 862 | ||
| Chapter 24 | 863 | ||
| Chapter 26 | 863 | ||
| Chapter 28 | 863 | ||
| Chapter 31 | 863 | ||
| Chapter 34 | 863 | ||
| Chapter 36 | 863 | ||
| Chapter 37 | 863 | ||
| Chapter 44 | 863 | ||
| Chapter 47 | 863 | ||
| Chapter 48 | 863 | ||
| Chapter 49 | 863 | ||
| Index | 864 | ||
| A | 864 | ||
| B | 867 | ||
| C | 868 | ||
| D | 871 | ||
| E | 873 | ||
| F | 874 | ||
| G | 876 | ||
| H | 876 | ||
| I | 877 | ||
| J | 879 | ||
| K | 879 | ||
| L | 879 | ||
| M | 880 | ||
| N | 882 | ||
| O | 884 | ||
| P | 885 | ||
| Q | 888 | ||
| R | 888 | ||
| S | 889 | ||
| T | 891 | ||
| U | 893 | ||
| V | 893 | ||
| W | 894 | ||
| X | 894 | ||
| Y | 894 | ||
| Z | 894 | ||
| The Joint Commissions Do Not Use list | 895 | ||
| NANDA-I Nursing Diagnoses, 2012–2014 | 896 | ||
| Domain 1: Health Promotion | 896 | ||
| Domain 2: Nutrition | 896 | ||
| Domain 3: Elimination and Exchange | 896 | ||
| Domain 4: Activity/Rest | 896 | ||
| Domain 5: Perception/Cognition | 896 | ||
| Domain 6: Self-Perception | 896 | ||
| Domain 7: Role Relationships | 896 | ||
| Online_Appendices A-H | app_a.1 | ||
| Inside back cover | ibc1 |